Icon Beats Q4 Estimates, Prepares for Revenue Uptick in 2013
Ireland-based CRO Icon unveiled higher than expected revenue and backlog increases in 2012 when compared to 2011, and the company expects even stronger results in 2013.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs